
#ASCO26 has released most abstracts. I will break down GI cancer-related abstracts to five tables: Important studies Interesting studies Important negative studies Novel agents Practice re-affirming studies Abstracts that have not been released but are eagerly anticipated: RASolute-302, EMERALD-3, CIRCULATE (AIO), Episode-3, BREAKWATER update, PUMP. Please see the tables below for the first two tables (important studies, interesting studies). More to come. @OncoAlert @jgong15 #GIcancer























